National Institute for Health and Care Excellence: Standards

(asked on 11th May 2022) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what plans they have to address capacity issues being experienced by the National Institute of Health and Care Excellence.


Answered by
Lord Kamall Portrait
Lord Kamall
This question was answered on 17th May 2022

The National Institute for Health and Care Excellence (NICE) commits to publishing draft recommendations on new medicines approximately at the time of licensing, with final guidance within three months of licensing wherever possible. In 2021/22, guidance was issued within three months of a licence for 100% of new medicines where NICE proceeded to appraisal and 98 technology appraisals were published, meeting the target in its business plan.

The Department holds regular accountability meetings with NICE to discuss a range of issues, including the delivery of its commitments. NICE is prioritising the flexibility and capacity of its technology appraisal programme through a more proportionate approach to assessments. From April 2023, NICE aims to expand its capacity for technology appraisals by 20% to respond to the increasing numbers of topics referred for appraisal.

Reticulating Splines